Racial and Ethnic Considerations for the Clinical Practice of Psychopharmacology and Research Methodology: A Narrative Review of the Growing Body of Literature.

IF 1 4区 医学 Q3 PSYCHIATRY Journal of Psychiatric Practice Pub Date : 2025-03-01 DOI:10.1097/PRA.0000000000000845
Andrew Toyin Olagunju, Jeffrey Wang, Bassey Edet, Obiora E Onwuameze, Matthew Macaluso
{"title":"Racial and Ethnic Considerations for the Clinical Practice of Psychopharmacology and Research Methodology: A Narrative Review of the Growing Body of Literature.","authors":"Andrew Toyin Olagunju, Jeffrey Wang, Bassey Edet, Obiora E Onwuameze, Matthew Macaluso","doi":"10.1097/PRA.0000000000000845","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Race and ethnicity are important but often underexamined factors in psychopharmacology research and clinical practice. This review summarizes key findings on ethnic and racial considerations for researchers, medical practitioners, and clinical psychopharmacologists. We hope it serves an important function in highlighting a critically important, yet still emerging issue to inform research and therapeutic use of psychotropics to improve their effectiveness.</p><p><strong>Methods: </strong>We queried major databases (PubMed, PsycInfo, Embase) using a search strategy that included MeSH (Medical Subject Headings) terms and conducted a snowball search to identify studies addressing ethnic or racial aspects of psychopharmacological practice. Findings were synthesized and presented in clinically applicable areas.</p><p><strong>Results: </strong>The clinically relevant ethnic and racial considerations identified in this review can be broadly categorized into the following areas: (1) variations in therapeutic and adverse dose-responses (eg, non-Whites attaining therapeutic and adverse effects at lower doses with certain medications); (2) interracial differences in prescription patterns of psychotropics, with lower prescription rates among under-represented minority groups and greater use of first-generation antipsychotics in African American populations; and (3) variations in attitudes toward psychopharmacotherapy. While differences in medication response can be partially explained by genetic variations in metabolism or receptor sensitivity, systemic racism and social determinants of health continue to have an influence.</p><p><strong>Conclusions: </strong>The evidence base for ethnic and racial considerations in psychopharmacology research and clinical practice continues to evolve with growing consideration for diversity and inclusivity in training, research, and clinical practice. This is critical to promoting equitable and effective care to a diverse population. Key questions are highlighted to draw attention to these critical needs.</p>","PeriodicalId":16909,"journal":{"name":"Journal of Psychiatric Practice","volume":"31 2","pages":"56-64"},"PeriodicalIF":1.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychiatric Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/PRA.0000000000000845","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Race and ethnicity are important but often underexamined factors in psychopharmacology research and clinical practice. This review summarizes key findings on ethnic and racial considerations for researchers, medical practitioners, and clinical psychopharmacologists. We hope it serves an important function in highlighting a critically important, yet still emerging issue to inform research and therapeutic use of psychotropics to improve their effectiveness.

Methods: We queried major databases (PubMed, PsycInfo, Embase) using a search strategy that included MeSH (Medical Subject Headings) terms and conducted a snowball search to identify studies addressing ethnic or racial aspects of psychopharmacological practice. Findings were synthesized and presented in clinically applicable areas.

Results: The clinically relevant ethnic and racial considerations identified in this review can be broadly categorized into the following areas: (1) variations in therapeutic and adverse dose-responses (eg, non-Whites attaining therapeutic and adverse effects at lower doses with certain medications); (2) interracial differences in prescription patterns of psychotropics, with lower prescription rates among under-represented minority groups and greater use of first-generation antipsychotics in African American populations; and (3) variations in attitudes toward psychopharmacotherapy. While differences in medication response can be partially explained by genetic variations in metabolism or receptor sensitivity, systemic racism and social determinants of health continue to have an influence.

Conclusions: The evidence base for ethnic and racial considerations in psychopharmacology research and clinical practice continues to evolve with growing consideration for diversity and inclusivity in training, research, and clinical practice. This is critical to promoting equitable and effective care to a diverse population. Key questions are highlighted to draw attention to these critical needs.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
精神药理学临床实践和研究方法的种族和民族考虑:对越来越多文献的叙述性回顾。
背景:种族和民族是精神药理学研究和临床实践中的重要因素,但往往未得到充分研究。本综述为研究人员、医疗从业人员和临床精神药理学家总结了有关民族和种族因素的重要发现。我们希望这篇综述能发挥重要作用,突出一个极其重要但仍在出现的问题,为精神药物的研究和治疗使用提供信息,以提高其有效性:我们使用包含 MeSH(医学主题词表)术语的搜索策略查询了主要数据库(PubMed、PsycInfo、Embase),并进行了滚雪球式搜索,以确定涉及精神药理学实践中民族或种族方面的研究。对研究结果进行了综合,并在临床适用领域进行了介绍:本综述中发现的与临床相关的民族和种族因素可大致分为以下几个方面:(1) 治疗和不良剂量反应的差异(例如,非白人在使用某些药物时剂量较低却能达到治疗和不良反应的效果);(2) 精神药物处方模式的种族间差异,代表性不足的少数群体处方率较低,而非裔美国人中第一代抗精神病药物的使用率较高;(3) 对精神药物治疗态度的差异。虽然新陈代谢或受体敏感性方面的遗传差异可以部分解释药物反应的差异,但系统性种族主义和健康的社会决定因素仍会产生影响:在精神药理学研究和临床实践中考虑民族和种族因素的证据基础仍在不断发展,在培训、研究和临床实践中越来越多地考虑到多样性和包容性。这对于促进为不同人群提供公平有效的治疗至关重要。本文强调了一些关键问题,以引起人们对这些关键需求的关注。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.30
自引率
10.50%
发文量
159
审稿时长
>12 weeks
期刊介绍: Journal of Psychiatric Practice® seizes the day with its emphasis on the three Rs — readability, reliability, and relevance. Featuring an eye-catching style, the journal combines clinically applicable reviews, case studies, and articles on treatment advances with practical and informative tips for treating patients. Mental health professionals will want access to this review journal — for sharpening their clinical skills, discovering the best in treatment, and navigating this rapidly changing field. Journal of Psychiatric Practice combines clinically applicable reviews, case studies, and articles on treatment advances with informative "how to" tips for surviving in a managed care environment.
期刊最新文献
Enhancing Training and Education on Treatment Readiness in Personality Disorders: A Case-based Discussion. A Comparative Analysis of the Levels of Insight Between Elderly and Nonelderly Patients Diagnosed With Schizophrenia. From the Editor: Intensive Care. Psychotherapy and AI 2.0: An Update. A Qualitative Study of Treatment Experiences Among Youth With Misophonia and Their Parents.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1